233 reports of this reaction
3.5% of all DESVENLAFAXINE reports
#2 most reported adverse reaction
TOXICITY TO VARIOUS AGENTS is the #2 most commonly reported adverse reaction for DESVENLAFAXINE, manufactured by Actavis Pharma, Inc.. There are 233 FDA adverse event reports linking DESVENLAFAXINE to TOXICITY TO VARIOUS AGENTS. This represents approximately 3.5% of all 6,688 adverse event reports for this drug.
Patients taking DESVENLAFAXINE who experience toxicity to various agents should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXICITY TO VARIOUS AGENTS is moderately reported among DESVENLAFAXINE users, representing a notable but not dominant share of adverse events.
In addition to toxicity to various agents, the following adverse reactions have been reported for DESVENLAFAXINE:
The following drugs have also been linked to toxicity to various agents in FDA adverse event reports:
TOXICITY TO VARIOUS AGENTS has been reported as an adverse event in 233 FDA reports for DESVENLAFAXINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXICITY TO VARIOUS AGENTS accounts for approximately 3.5% of all adverse event reports for DESVENLAFAXINE, making it one of the most commonly reported side effect.
If you experience toxicity to various agents while taking DESVENLAFAXINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.